Riskpilot← Back to searchSign inGet full accessBIOMED CLUSTER AS
ASActiveOrg 912971880Stasjonsveien 33A, 0772 OsloForskning og utviklingsarbeid innen bioteknologi · NACE 72110Est. 20130 employees
Revenue 2023
NOK 0
EBITDA margin
—
Equity ratio
79.3%
Financial strength
Net profit 2023
NOK 0
+100% vs 2022
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 0 | +100% |
| Total assets | NOK 19K | +0% |
| Equity | NOK 15K | +0% |
| Employees | 0 | — |
Legal name
BIOMED CLUSTER AS
Org number
912971880
Legal form
Aksjeselskap
NACE code
72110 · Forskning og utviklingsarbeid innen bioteknologi
Founded
23. desember 2013
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Tao zhang
Company purpose
Konsulentvirksomhet innen forretningsutviklinger og kommersialisering av teknologi innen bioteknologi i både asia og norge, salg av biokjemiske reagenser og andre produkter for forskning og bioteknologi industri og annet som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender. Selskapet har som formål å tilbud konsultasjon til forretningsutvikling spesialt innen bioteknologi i både asia og norge, å kommersialisere bioteknologi og selge biokjemisks reagenser for forskning og bioteknologi industrien.
Address
Stasjonsveien 33A, 0772 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | 0 | −0 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 | −0 | 0 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | −0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | −0 | 0 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 19 | 19 | 19 | 19 | 19 |
| Equity | 15 | 15 | 15 | 15 | 15 |
| Long-term debt | 5 | 5 | 5 | 5 | 5 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 |
| Total debt | 5 | 5 | 5 | 5 | 5 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192023
Equity ratio
79.3%
This company
38.2%
Market median
+108% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOMED CLUSTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tao Zhang | Chairman | 0 companies |